Staphylococcus aureus endocarditis: a consequence of medical progress.

CONTEXT The global significance of infective endocarditis (IE) caused by Staphylococcus aureus is unknown. OBJECTIVES To document the international emergence of health care-associated S aureus IE and methicillin-resistant S aureus (MRSA) IE and to evaluate regional variation in patients with S aureus IE. DESIGN, SETTING, AND PARTICIPANTS Prospective observational cohort study set in 39 medical centers in 16 countries. Participants were a population of 1779 patients with definite IE as defined by Duke criteria who were enrolled in the International Collaboration on Endocarditis-Prospective Cohort Study from June 2000 to December 2003. MAIN OUTCOME MEASURE In-hospital mortality. RESULTS S aureus was the most common pathogen among the 1779 cases of definite IE in the International Collaboration on Endocarditis Prospective-Cohort Study (558 patients, 31.4%). Health care-associated infection was the most common form of S aureus IE (218 patients, 39.1%), accounting for 25.9% (Australia/New Zealand) to 54.2% (Brazil) of cases. Most patients with health care-associated S aureus IE (131 patients, 60.1%) acquired the infection outside of the hospital. MRSA IE was more common in the United States (37.2%) and Brazil (37.5%) than in Europe/Middle East (23.7%) and Australia/New Zealand (15.5%, P<.001). Persistent bacteremia was independently associated with MRSA IE (odds ratio, 6.2; 95% confidence interval, 2.9-13.2). Patients in the United States were most likely to be hemodialysis dependent, to have diabetes, to have a presumed intravascular device source, to receive vancomycin, to be infected with MRSA, and to have persistent bacteremia (P<.001 for all comparisons). CONCLUSIONS S aureus is the leading cause of IE in many regions of the world. Characteristics of patients with S aureus IE vary significantly by region. Further studies are required to determine the causes of regional variation.

[1]  M. Gail,et al.  Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial , 2005, Gynecologic oncology.

[2]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Michael Soyka,et al.  Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment. , 2004, Alcohol and alcoholism.

[4]  R. Darouiche,et al.  Treatment of infections associated with surgical implants. , 2004, The New England journal of medicine.

[5]  P. Heidenreich,et al.  Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. , 2004, American heart journal.

[6]  Susan K. Johnson,et al.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. , 2003, JAMA.

[7]  P. Bendtsen,et al.  A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. , 2003, Alcoholism, clinical and experimental research.

[8]  Jennie Z Ma,et al.  Oral topiramate for treatment of alcohol dependence: a randomised controlled trial , 2003, The Lancet.

[9]  M. Soyka,et al.  Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective. , 2003, The American journal on addictions.

[10]  C. Cabell,et al.  Progress toward a global understanding of infective endocarditis. Lessons from the International Collaboration on Endocarditis. , 2003, Cardiology clinics.

[11]  Cathy A Petti,et al.  Staphylococcus aureus bacteremia and endocarditis. , 2003, Cardiology clinics.

[12]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[13]  G. Gessa,et al.  Baclofen suppresses motivation to consume alcohol in rats , 2003, Psychopharmacology.

[14]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[15]  G. Gessa,et al.  Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. , 2002, Alcohol and alcoholism.

[16]  K. McDonald,et al.  Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. , 2002, American heart journal.

[17]  V. Fowler,et al.  Staphylococcus aureus bacteremia and endocarditis. , 2002, Infectious disease clinics of North America.

[18]  Rajita Sinha,et al.  Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis , 2002, Psychopharmacology.

[19]  Vance G Fowler,et al.  Changing patient characteristics and the effect on mortality in endocarditis. , 2002, Archives of internal medicine.

[20]  L. Figueiredo,et al.  Infective endocarditis (IE) first diagnosed at autopsy: analysis of 31 cases in Ribeirão Preto, Brazil. , 2001, Revista do Instituto de Medicina Tropical de Sao Paulo.

[21]  G. Koob.  Animal models of craving for ethanol. , 2000, Addiction.

[22]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Verhoef,et al.  Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  P. Asfar,et al.  Nosocomial endocarditis in the intensive care unit: An analysis of 22 cases , 2000, Critical care medicine.

[25]  R. Anton,et al.  Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. , 1999, The American journal of psychiatry.

[26]  N. Frimodt-Møller,et al.  Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. , 1999, Archives of internal medicine.

[27]  R. Haug.  New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings , 1994 .

[28]  C. Watanakunakorn.  Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases. , 1994, Archives of internal medicine.

[29]  J. Grotta,et al.  Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Circulation.

[30]  D. Durack,et al.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. , 1994, The American journal of medicine.

[31]  L. Saravolatz,et al.  Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection , 1992, Annals of Internal Medicine.

[32]  N. Larocca,et al.  High‐dose oral baclofen , 1991, Neurology.

[33]  B. R. Reddy,et al.  Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. , 1991, Annals of internal medicine.

[34]  P. Small,et al.  Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users , 1990, Antimicrobial Agents and Chemotherapy.

[35]  L. Reller,et al.  Short-course therapy for catheter-associated Staphylococcus aureus bacteremia. , 1989, Archives of internal medicine.

[36]  M. Terpenning,et al.  Hospital-acquired infective endocarditis. , 1988, Archives of internal medicine.

[37]  J. Mylotte,et al.  Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. , 1987, Reviews of infectious diseases.

[38]  N. Frimodt-Møller,et al.  Staphylococcus aureus Endocarditis: A Review of 119 Cases , 1986 .

[39]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[40]  M. Sande,et al.  Staphylococcus aureus Endocarditis: Clinical Manifestations in Addicts and Nonaddicts , 1983, Medicine.

[41]  M. Sande,et al.  Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. , 1982, Annals of internal medicine.

[42]  D. Tillman,et al.  Clinical value of teichoic acid antibody titers in the diagnosis and management of the staphylococcemias. , 1980, The Western journal of medicine.

[43]  G. Williams,et al.  10 YEARS OF INFECTIVE ENDOCARDITIS AT ST. BARTHOLOMEW'S HOSPITAL: ANALYSIS OF CLINICAL FEATURES AND TREATMENT IN RELATION TO PROGNOSIS AND MORTALITY , 1980, The Lancet.

[44]  K. Crossley,et al.  Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. , 1976, Annals of internal medicine.

[45]  C. M. Nolan,et al.  Staphylococcus aureus bacteremia: Current clinical patterns , 1976 .

[46]  J. Grotta,et al.  Guidelines for the Management of Patients With Acute Ischemic Stroke A Statement for Healthcare Professionals , 2005 .

[47]  D J Rohsenow,et al.  Does Urge To Drink Predict Relapse After Treatment? , 1999, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[48]  C. Watanakunakorn.  Increasing importance of intravascular device-associated Staphylococcus aureus endocarditis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  G. Gottlieb,et al.  Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). , 1998, Journal of the American College of Cardiology.

[51]  M. Fernández-Guerrero,et al.  Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.